Fortrea Holdings (FTRE) Gross Margin (2022 - 2026)
Fortrea Holdings (FTRE) reported Gross Margin of 19.42% for Q1 2026, up 153.0% on a YoY basis from 7.68% in Q1 2025, and down 2.17% quarter-over-quarter from 19.85% in Q4 2025.
Fortrea Holdings (FTRE) Gross Margin (2022 - 2026) Analysis & Trends
Fortrea Holdings has reported Gross Margin for 5 years, with the latest figure at 19.42% in Q1 2026.
- For the quarter ending Q1 2026, Gross Margin rose 153.0% year-over-year to 19.42%; the trailing twelve-month figure through Mar 2026 stood at 18.86% (down 135.0% YoY), and the FY2025 full-year result was 18.5%, down 131.0% from the prior year.
- Gross Margin for Q1 2026 stood at 19.42%, down from 19.85% in the prior quarter.
- The five-year high for Gross Margin was 47.27% in Q4 2022, with the low at 16.3% in Q1 2024.
- Historically, Gross Margin has averaged 21.72% across 5 years, with a median of 20.46% in 2024.
- Annual changes were most pronounced in 2023 — Gross Margin tumbled 2870 bps — and 2024, when it soared 164 bps.
- Fortrea Holdings' Gross Margin stood at 47.27% in 2022, then slumped by 61 bps to 18.57% in 2023, then gained by 9 bps to 20.22% in 2024, then retreated by 2 bps to 19.85% in 2025, then dropped by 2 bps to 19.42% in 2026.
- The last three Gross Margin figures came in at 19.42% (Q1 2026), 19.85% (Q4 2025), and 17.5% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 79.04% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 86.85% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Fortrea Holdings | 1.43 Bn | 1.28 Bn | 123.60 Mn | 19.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.42% |
| Dec 31, 2025 | 19.85% |
| Sep 30, 2025 | 17.50% |
| Jun 30, 2025 | 18.79% |
| Mar 31, 2025 | 17.89% |
| Dec 31, 2024 | 20.22% |
| Sep 30, 2024 | 21.97% |
| Jun 30, 2024 | 20.70% |
| Mar 31, 2024 | 16.30% |
| Dec 31, 2023 | 18.57% |
| Sep 30, 2023 | 21.01% |
| Jun 30, 2023 | 21.57% |
| Mar 31, 2023 | 21.96% |
| Dec 31, 2022 | 47.27% |
| Sep 30, 2022 | 21.97% |
| Jun 30, 2022 | 22.54% |